Phaseline

Targets › ADRA2C

ADRA2C (Alpha-2C adrenergic receptor): drug programs, companies and trials

68 programs from 65 companies in 183 trials: 69 Phase 4, 50 Phase 2, 36 Phase 3, 28 Phase 1; Other, Psychiatry, Cardiovascular; next expected readout Nov 2026.

Alpha-2 adrenergic receptors are G protein-coupled receptors for catecholamines that activate the G(i/o) protein pathway, thereby promoting adenylyl cyclase inhibition, ERK1/2 stimulation, and voltage-gated calcium channels suppression. Control a variety of physiological processes, such as regulation of blood pressure, lipolysis and insulin release. (UniProt, P18825)

Open in Phaseline: the race on ADRA2C, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of Pennsylvania2-[18F]-FA
Voltage-gated calcium channel modulator
CHRNA4, OPRK1, OPRD1, OPRM1, UL51, ADRA2A, ADRA2C, ADRA2B, Ion channels, CACNB4, CACNB2, CACNB1, CACNB3, TNF, SLC6A4, HTR2A, HTR2C, FKBP1A, CD86, CD80, PDE4A, PDE4D, PDE4B, PDE4C, PDE3A, CHRNB2, STNPhase 4Alcohol Use Disorder; Acute Kidney Injury; Insomnia; Giant Cell Arteritis …Nov 2026
Cooper Norcross HealthClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Neonatal Abstinence SyndromeDec 2026
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,Brimonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4GlaucomaDec 2026
Sunnybrook Health Sciences CentreDexmedetomidine Hydrochloride
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4DeliriumDec 2026
Cairo UniversityEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Incidence of Post-spinal HypotensionDec 2026
Mansoura UniversityEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean DeliveryDec 2026
Mansoura UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean DeliveryDec 2026
John O'TooleClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Lumbar Spinal StenosisFeb 2027
Peking University First HospitalIntranasal dexmedetomidine-esketamine
Combination of alpha-2 adrenergic agonist and NMDA receptor antagonist
ADRA2A, NMDAR, ADRA2B, ADRA2C, GRIN1Phase 4Adenotonsillectomy; General AnesthesiaFeb 2027
Region SkaneClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Osteo Arthritis of the KneeMar 2027
Sohag UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Patients Undergoing Orthopedic Hip Surgery Under Spinal AnesthesiaMar 2027
ARS PharmaceuticalsEpinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Allergic Reactions; Knee Arthroplasty, Total; Cardiac Arrest, Out-Of-Hospital; Shock Hypovolemic …Apr 2027
Icahn School of Medicine at Mount SinaiEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4LaborMay 2027
James J. Peters Veterans Affairs Medical CenterDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4HypotensionJun 2027
University of California, DavisNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension and ShockJun 2027
University of Sao Paulo General Hospitalclonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Cocaine Use DisorderJul 2027
Seoul National University HospitalPhenoxybenzamine
Adrenergic receptor alpha antagonist
ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1BPhase 4PheochromocytomaAug 2027
University Hospital Dubravaclonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Inguinal HerniaSep 2027
Aarhus University HospitalLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Intracerebral HaemorrhageSep 2027
Damanhour Teaching HospitalDexmedetomidine Hydrochloride
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4AnalgesiaDec 2027
University of AlbertaNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4VasoconstrictionDec 2027
Columbia UniversityClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Cesarean DeliveryMay 2028
Children's Hospital Medical Center, CincinnatiGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 4Attention-Deficit/Hyperactivity Disorder (ADHD)Feb 2030
Dalian Municipal Central HospitalEphedrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension Drug-Induced–
Nebraska Methodist Health SystemLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Postpartum Preeclampsia–
Tunis UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Sepsis, Severe–
Dalian Municipal Central HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Hypotension Drug-Induced–
Hassan II UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 4Cesarean Section Complications–
NHS Greater Glasgow and ClydeNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3SepsisNov 2026
Odense University HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3ShockDec 2026
Alcon ResearchApraclonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 3Ocular HyperemiaJan 2027
Wake Forest University Health SciencesClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 3PTSDMar 2027
Jagiellonian UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Blood Pressure ManagementJun 2027
Hospital do CoracaoNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Septic ShockAug 2027
University Hospital, BordeauxNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Stroke, AcuteAug 2027
Loma Linda UniversityLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Postpartum ComplicationDec 2027
Stanford UniversityTizanidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 3Chronic PainJan 2028
Acer TherapeuticsCeliprolol (ACER-002)
Beta-2 adrenergic receptor partial agonist; Adrenergic receptor alpha-2 antagonist; Beta-1 adrenergic receptor antagonist
ADRB2, ADRA2A, ADRA2C, ADRA2B, ADRB1Phase 3Vascular Ehlers-Danlos SyndromeMar 2029
University of Turin, ItalyNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 3Critical Illness–
Santen SASOxymetazoline (STN1013800)
Adrenergic receptor alpha agonist
ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1BPhase 3Acquired Blepharophimosis; Sleep Apnea; Perioperative Respiratory Adverse Events; Nasal Obstruction–
University of Maryland, BaltimoreLofexidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Opioid WithdrawalNov 2026
Washington State UniversityMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Stimulant Use DisorderDec 2026
University of Triestemirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2RETT Syndrome With Proven MECP2 MutationDec 2026
Teikoku Pharma USADexmedetomidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2AgitationMay 2027
University of AarhusNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2HypotensionDec 2027
Giuseppe Cullaro, MDDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2Acute Kidney InjuryDec 2027
M.D. Anderson Cancer CenterMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Advanced CancerDec 2027
Copenhagen University Hospital, RigshospitaletClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Emergence DeliriumJan 2028
Hartford HospitalTizanidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Post OperativeJul 2028
Stanford UniversityGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2DepressionOct 2028
Indiana UniversityGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Alcohol Use DisorderAug 2029
University of California, IrvineMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Glioma of BrainDec 2030
Universidade Federal do Rio de JaneiroClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Hernia, Umbilical–
Guangzhou Novaken PharmDexmedetomidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Preoperative Sedation; Emergence Delirium; Laceration of Skin; Vaginal Delivery …–
Yale UniversityGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Alcohol Use–
OrygenGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Cannabis Use Disorder–
BioCorRx Pharmaceuticals IncLofexidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 2Opioid Withdrawal (Disorder)–
Tarian PharmaTAR-0520 Gel
Brimonidine tartrate - selective alpha-2 adrenergic receptor agonist
ADRA2A, ADRA2B, ADRA2CPhase 2EGFR Inhibitor-associated Rash–
Kingston Health Sciences Centrenorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 2Shock–
Geriatric Hospital of Nanjing Medical UniversityNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1UrolithiasisDec 2026
University of Alabama at BirminghamLabetalol
Adrenergic receptor antagonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Hypertension in PregnancyDec 2026
BioXcel TherapeuticsDexmedetomidine (BXCL501)
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 1SchizophreniaJul 2027
University of Kansas Medical CenterClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 1Blood PressureAug 2027
Satish R. RajClonidine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 1TachycardiaDec 2029
Stephen G. KalerDroxidopa
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Menkes DiseaseJun 2030
Research Institute of Ophthalmology, EgyptDexmedetomidine Hydrochloride
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 1Patients Undergoing External Dacrocystorhinostomy Operations–
Rutgers, The State University of New JerseyGuanfacine
Adrenergic receptor alpha-2 agonist
ADRA2A, ADRA2C, ADRA2BPhase 1Mindfulness–
Brigham and Women's HospitalNorepinephrine
Adrenergic receptor agonist
ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2CPhase 1Hypertension–

Conditions

Cesarean Delivery (4) Delirium (4) Emergence Delirium (3) Breast Cancer (3) Anesthesia (3) Alcohol Use Disorder (3) Shock (3) Laceration of Skin (2) Postoperative Pain (2) General Anesthesia (2) Insomnia (2) Agitation (2)

Modalities

small molecule (62), protein or peptide (2), mixed (1)

Companies

Mansoura University (2) Stanford University (2) Dalian Municipal Central Hospital (2) University of Kansas Medical Center (1) Guangzhou Novaken Pharm (1) Nebraska Methodist Health System (1) Copenhagen University Hospital, Rigshospitalet (1) Universidade Federal do Rio de Janeiro (1) Seoul National University Hospital (1) Wake Forest University Health Sciences (1) M.D. Anderson Cancer Center (1) Icahn School of Medicine at Mount Sinai (1) Hospital do Coracao (1) Indiana University (1) Tunis University (1) Research Institute of Ophthalmology, Egypt (1) Santen SAS (1) University of Maryland, Baltimore (1) Geriatric Hospital of Nanjing Medical University (1) University Hospital Dubrava (1)

Related targets

ADRA2A (68) ADRA2B (37) ADRA1A (31) ADRB1 (30) ADRB2 (30) HTR2A (5) HTR2C (5) ADRA1D (2) ADRA1B (2) CHRNA4 (1) OPRK1 (1) OPRD1 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.